Results 311 to 320 of about 6,037,422 (381)

Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial. [PDF]

open access: yesReprod Biol Endocrinol, 2020
Llácer J   +8 more
europepmc   +1 more source

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

open access: bronze, 2003
Oliver W. Press   +8 more
openalex   +1 more source

Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation

open access: yesJournal of Assisted Reproduction and Genetics, 2007
M. Arslan   +5 more
semanticscholar   +1 more source

Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses

open access: yes
Cancer Communications, EarlyView.
Seungbyn Baek   +12 more
wiley   +1 more source

Adjuvant External Beam Radiotherapy in Differentiated Thyroid Cancers: An Audit of Clinical Practice, Adapting to New Evidence

open access: yesHead &Neck, EarlyView.
ABSTRACT Introduction There is limited evidence on the role of adjuvant external beam radiotherapy in differentiated thyroid cancer (DTC). Methods We conducted a retrospective study of patients with DTC treated with adjuvant Intensity Modulated radiotherapy (IMRT) from 2011 to 2024.
Sarbani Ghosh Laskar   +17 more
wiley   +1 more source

Somatic cell reprogramming for Parkinson's disease treatment

open access: yesIbrain, Volume 11, Issue 1, Page 59-73, Spring 2025.
The fundamental purpose of cell reprogramming to treat Parkinson's disease is to generate dopaminergic neurons (DAN) and do transplantation. There are two ways to accomplish this. One method is to induce cells into induced DA neurons (iDAN) directly or to induce cells into induced pluripotent stem cells and ultimately into iDAN in vitro. Another option
Xiaozhuo Li, Kevin Fang, Fengping Wang
wiley   +1 more source

Follow-Up Results of a Phase II Study of Ibritumomab Tiuxetan Radioimmunotherapy in Patients with Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

open access: green, 2004
Russell J. Schilder   +9 more
openalex   +2 more sources

Remolding Microenvironmental Homeostasis for Enhancing Regenerative Hypertrophic Scar Treatment Based on Functionalized Microneedles

open access: yesInterdisciplinary Materials, EarlyView.
This study explores the dysregulated “mitophagy–apoptosis–inflammation” axis in hypertrophic scar (HS) pathophysiology and proposes a synergistic therapy to restore microenvironmental homeostasis. By targeting mitochondrial dysfunction and inflammatory signaling, the strategy enhances scar regression, providing a novel clinical approach for HS ...
Shengjie Jiang   +11 more
wiley   +1 more source

Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Prostate cancer is a common malignancy that in 5%–30% leads to treatment‐resistant and highly aggressive disease. Metastasis‐potential and treatment‐resistance is thought to rely on increased plasticity of the cancer cells—a mechanism whereby cancer cells alter their identity to adapt to changing environments or therapeutic pressures to create
Kira Furlano   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy